Luke M Beshar's Net Worth
$18.6 Million
Who is Luke M Beshar?
Luke M Beshar has an estimated net worth of $18.6 Million. This is based on reported shares across multiple companies, which include REGENXBIO Inc., Omega Therapeutics, Inc., CAMBREX CORP, Trillium Therapeutics Inc., Protara Therapeutics, Inc., and NPS PHARMACEUTICALS INC.
SEC CIK
Luke M Beshar's CIK is 0001192128
Past Insider Trading and Trends
2013 was Luke M Beshar's most active year for acquiring shares with 14 total transactions. Luke M Beshar's most active month to acquire stocks was the month of October. 2006 was Luke M Beshar's most active year for disposing of shares, totalling 52 transactions. Luke M Beshar's most active month to dispose stocks was the month of October. 2006 saw Luke M Beshar paying a total of $1,929,270.00 for 116,837 shares, this is the most they've acquired in one year. In 2015 Luke M Beshar cashed out on 247,593 shares for a total of $3,975,628.99, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REGENXBIO Inc. (RGNX) Snapshot price: $13.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
$34.38 | -$782,892.16 |
0
|
Scheduled
|
Nov 29
| ||
Form 4
|
—
|
0
|
$43.05 | -$901,507.12 |
0
|
Scheduled
|
Nov 26 - Nov 27
| ||
Form 4
|
—
|
0
|
$37.43 | -$1,532,107.74 |
0
|
Scheduled
|
Nov 19 - Nov 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Omega Therapeutics, Inc. (OMGA) Snapshot price: $3.585
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CAMBREX CORP No price found
Executive Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -23.19K |
$11.01 | -$255,336.96 |
0
|
Oct 10
| |||
Form 4
| -20.89% | -6.13K |
$9.20 | -$90,388.75 | 23.19K |
Oct 2
| |||
Form 4
|
—
|
0
|
$10.32 | -$12,452.50 | 29.32K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| -10.72% | -3.52K |
$21.59 | -$76,016.63 | 29.32K |
Jan 29
| |||
Form 4
| +43.34% | 9.93K |
—
|
—
| 32.84K |
Jan 24
| |||
Form 4
| +3.06% | 700 |
$20.76 | -$100,346.04 | 23.61K |
Nov 20
| |||
Form 4
|
—
|
0
|
$21.51 | -$122,193.60 | 22.91K |
Nov 16 - Nov 17
| |||
Form 4
| +17.43% | 3.4K |
—
|
—
| 22.91K |
Jul 27
| |||
Form 4
| +76.57% | 8.93K |
—
|
—
| 20.59K |
Dec 31 - Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
| +205.74% | 7.85K |
—
|
—
| 11.66K |
Dec 31 - Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
∞
| 3.52K |
—
|
—
| 3.52K |
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trillium Therapeutics Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protara Therapeutics, Inc. (TARA) Snapshot price: $2.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +5.32% | 10K |
$3.10 | $31,000.00 | 198K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +5.62% | 10K |
$4.25 | $42,500.00 | 188K |
Mar 14
| |||
Form 4
| +5.95% | 10K |
$4.46 | $44,555.00 | 178K |
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
|
∞
| 168K |
—
|
—
| 168K |
Jan 9 - Jan 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||